Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.
Auger and Alpha emitters
PARP inhibition
PARP1 theranostic probes
PARP1 tracers
PET/SPECT imaging
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
06 Jul 2020
06 Jul 2020
Historique:
received:
11
06
2020
revised:
29
06
2020
accepted:
03
07
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
10
7
2020
Statut:
epublish
Résumé
The central paradigm of novel therapeutic approaches in cancer therapy is identifying and targeting molecular biomarkers. One such target is the nuclear DNA repair enzyme Poly-(ADP ribose) polymerase 1 (PARP1). Sensitivity to PARP inhibition in certain cancers such as gBRCA
Identifiants
pubmed: 32640708
pii: jcm9072130
doi: 10.3390/jcm9072130
pmc: PMC7408801
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Nucl Med. 2019 Apr;60(4):504-510
pubmed: 30389822
Bioconjug Chem. 2019 May 15;30(5):1331-1342
pubmed: 30973715
Science. 2017 Mar 17;355(6330):1152-1158
pubmed: 28302823
Radiology. 2017 Feb;282(2):453-463
pubmed: 27841728
Nat Biomed Eng. 2020 Mar;4(3):272-285
pubmed: 32165735
Mol Cancer Ther. 2019 Jul;18(7):1195-1204
pubmed: 31072830
J Neurosurg. 2017 Jan;126(1):191-200
pubmed: 27035164
Nat Commun. 2020 Jan 30;11(1):594
pubmed: 32001707
Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1922-5
pubmed: 21328671
Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7441-E7449
pubmed: 28827325
Pharmacol Rev. 2013 Sep 24;65(4):1214-56
pubmed: 24064460
Bioconjug Chem. 2018 Nov 21;29(11):3776-3782
pubmed: 30354077
J Nucl Med. 2018 Aug;59(8):1225-1233
pubmed: 29572254
Clin Cancer Res. 2020 Jun 15;26(12):2871-2881
pubmed: 32066626
Clin Cancer Res. 2017 Dec 1;23(23):7165-7170
pubmed: 28751443
J Thorac Oncol. 2019 Oct;14(10):1743-1752
pubmed: 31195178
Nucl Med Biol. 2020 May - Jun;84-85:80-87
pubmed: 32135475
Clin Cancer Res. 2018 Sep 1;24(17):4066-4071
pubmed: 29650751
ChemMedChem. 2014 Jul;9(7):1368-73
pubmed: 24596307
Mol Imaging Biol. 2016 Jun;18(3):386-92
pubmed: 26493053
Theranostics. 2019 Aug 14;9(21):6224-6238
pubmed: 31534547
Br J Cancer. 2011 Oct 11;105(8):1114-22
pubmed: 21989215
J Pharm Pharmacol. 2008 Aug;60(8):951-8
pubmed: 18644188
J Nucl Med. 2020 Jun;61(6):850-856
pubmed: 31676730
Bioorg Chem. 2019 Mar;83:242-249
pubmed: 30390553
J Med Chem. 2018 May 10;61(9):4103-4114
pubmed: 29630818
Cancer Res. 2016 Aug 1;76(15):4516-24
pubmed: 27261505
Nanomedicine (Lond). 2012 Aug;7(8):1225-33
pubmed: 22931448
EJNMMI Res. 2015 Dec;5(1):123
pubmed: 26337803
Drugs. 2018 Dec;78(18):1939-1946
pubmed: 30506138
Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):94-101
pubmed: 27069769
Front Oncol. 2013 Aug 19;3:215
pubmed: 23967404
Oncotarget. 2018 Dec 14;9(98):37080-37096
pubmed: 30647846
J Clin Invest. 2018 May 1;128(5):2116-2126
pubmed: 29509546
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1065-1078
pubmed: 28058462
Nat Commun. 2018 Jan 12;9(1):176
pubmed: 29330466
J Labelled Comp Radiopharm. 2020 Jul;63(9):419-425
pubmed: 32391930
Front Oncol. 2019 Jan 22;8:670
pubmed: 30723695
Bioorg Med Chem. 2014 Mar 1;22(5):1700-7
pubmed: 24503274
Nucl Med Biol. 2018 Nov;66:26-31
pubmed: 30195072
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Br J Cancer. 2014 Aug 12;111(4):651-9
pubmed: 25025963
Cancer Manag Res. 2019 May 10;11:4371-4390
pubmed: 31191001
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3472-3476
pubmed: 28587822
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Nucl Med Biol. 2016 Dec;43(12):752-758
pubmed: 27689533
Semin Nucl Med. 2008 Sep;38(5):358-66
pubmed: 18662557
Neuro Oncol. 2020 Apr 29;:
pubmed: 32347934
Clin Cancer Res. 2015 Oct 1;21(19):4257-61
pubmed: 26187614
Chem Soc Rev. 2005 Feb;34(2):153-63
pubmed: 15672179
Nat Commun. 2018 May 18;9(1):1991
pubmed: 29777137
Clin Cancer Res. 2020 Jul 1;26(13):3110-3116
pubmed: 32245901
Nano Lett. 2011 Feb 9;11(2):814-9
pubmed: 21210706
J Med Chem. 2015 Nov 12;58(21):8683-93
pubmed: 26469301
Environ Mol Mutagen. 2017 Jun;58(5):235-263
pubmed: 28485537
Biomater Sci. 2017 May 2;5(5):1041-1050
pubmed: 28378865
Int J Gynecol Cancer. 2019 May 22;:
pubmed: 31118216
J Nucl Med. 2017 Jul;58(7):1025-1030
pubmed: 28473593
EJNMMI Res. 2018 Jul 4;8(1):59
pubmed: 29974335
Mol Imaging. 2017 Jan-Dec;16:1536012117723786
pubmed: 28856922